Ding Yi, Chen Bin, Huang Jing, Zhang Wenli, Yang Hongjun, Deng Yongjian, Lin Jie, Wang Shuang, Zhang Xiangmei
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Department of Academic Research and Medical Training, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong 510515, P.R. China.
Oncol Rep. 2014 Aug;32(2):607-18. doi: 10.3892/or.2014.3241. Epub 2014 Jun 6.
The aim of the present study was to analyze the roles of T lymphoma invasion and metastasis 1 (Tiam1) in nasopharyngeal carcinoma (NPC) progression and its correlation with clinicopathological features, including the survival of patients with NPC. Tiam1 protein expression in NPC tissues was examined using immunohistochemistry. Reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence staining were performed to detect the expression of Tiam1 in 6 NPC cell lines. Stable Tiam1-overexpressing NPC cells using a transfection technique and Tiam1-silencing NPC cells using short hairpin RNA were constructed. Subsequently, MTT assay, plate and soft agar colony formation assays, cell adhesion, migration, invasion assays and experimental animal models were carried out to detect the biological functions of Tiam1 in vitro and in vivo. Immunohistochemical analysis revealed that Tiam1 had high expression in 96 of 140 (68.6%) paraffin-embedded archival NPC biopsies. Tiam1 overexpression was significantly associated with N classification (P=0.004), distant metastasis (P=0.042) and clinical stage (P=0.042). Patients with higher levels of Tiam1 expression had poorer overall survival (P=0.002). Multivariate analysis revealed that Tiam1 expression is an independent prognostic indicator for the overall survival of NPC patients. Using the approaches of exogenous overexpression and the knockdown of Tiam1 expression, respectively, it was confirmed that Tiam1 promoted cell proliferation, adhesion, invasion and migration in vitro and in vivo. These data support the notion that Tiam1 plays an important role in the progression of NPC, and the overexpression of Tiam1 is associated with malignant phenotypes of NPC.
本研究旨在分析T淋巴瘤侵袭转移蛋白1(Tiam1)在鼻咽癌(NPC)进展中的作用及其与临床病理特征的相关性,包括NPC患者的生存率。采用免疫组织化学法检测NPC组织中Tiam1蛋白的表达。进行逆转录聚合酶链反应(RT-PCR)和免疫荧光染色以检测6种NPC细胞系中Tiam1的表达。利用转染技术构建稳定过表达Tiam1的NPC细胞,利用短发夹RNA构建Tiam1沉默的NPC细胞。随后,进行MTT法、平板和软琼脂集落形成试验、细胞黏附、迁移、侵袭试验以及实验动物模型,以检测Tiam1在体外和体内的生物学功能。免疫组织化学分析显示,在140例石蜡包埋的存档NPC活检组织中,有96例(68.6%)Tiam1呈高表达。Tiam1过表达与N分期(P=0.004)、远处转移(P=0.042)和临床分期(P=0.042)显著相关。Tiam1表达水平较高的患者总生存期较差(P=0.002)。多因素分析显示,Tiam1表达是NPC患者总生存期的独立预后指标。分别采用外源性过表达和敲低Tiam1表达的方法,证实Tiam1在体外和体内均促进细胞增殖、黏附、侵袭和迁移。这些数据支持Tiam1在NPC进展中起重要作用的观点,且Tiam1的过表达与NPC的恶性表型相关。